Survivor, volunteer and top PurpleStride fundraiser John Walmsley spoke with PanCAN’s Paula Mukherjee about his commitment to ...

The Gift is Part of PanCAN’s $250 Million All Together We Can Campaign to Accelerate Breakthrough Research, Expand Patient Support, and Champion a Thriving Community LOS ANGELES, CALIF. – (July 7, ...

One of the most common conditions associated with pancreatic cancer may also be one of the least understood: Cancer cachexia. Sometimes known as wasting syndrome, cancer cachexia is the loss of 5% or ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

The U.S. Food and Drug Administration (FDA) has approved a wearable medical device used in combination with a standard chemotherapy regimen for the treatment of adult patients with locally advanced ...

I’ve been advocating for patients with pancreatic cancer for 27 years. Never have I seen a year with so much uncertainty and turmoil in federal cancer research funding. But despite the instability and ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

LOS ANGELES, Calif. – (January 13, 2026) – Pancreatic cancer remains the third-leading cause of cancer-related deaths in the United States, behind lung and colorectal cancers. According to the ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...